Cationic Metallatricarbadecaboranyl Analogues of Metallocene Antitumor Agents: Synthesis, Structure, and Antineoplastic Activity of [1-(η5-C5H5)Fe-2-Me-2,3,4-C 3B7H9]+[X]- Salts (X- = AsF-6, SbF-6)

Angewandte Chemie (International Edition in English)

Volumn 36, Issue 20, 1997, Pages 2228-2230

  Wasczcak, Michael D ^a   Lee, Christian C ^b   Hall, Iris H ^b   Carroll, Patrick J ^a   Sneddon, Larry G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Antitumor agents; Boron; Iron; Metallocenes; Topoisomerase

Indexed keywords

EID: 0030693833     PISSN: 05700833     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.199722281     Document Type: Article

References (22)

1. S. E. Sherman, S. J. Lippard, Chem. Rev. 1987, 87, 1153-1181, and references therein.
2. a) K. E. Dombrowski, W. Baldwin, J. E. Sheats, J. Organomet. Chem. 1986, 302, 281-306;
3. b) P. Köpf-Maier, H. Köpf, Structure Bonding 1988, 70, 103-185.
4. a) C. A. Plumb, P. J. Carroll, L. G. Sneddon, Organometallics 1992, 11, 1665-1671;
5. b) ibid. 1992, 11, 1672-1680.
6. a) P. Köpf-Maier, H. Köpf, E. W. Neuse, Angew. Chem. 1984, 96, 446-447; Angew. Chem. Int. Ed. Engl. 1984, 23, 456-457;
7. a) P. Köpf-Maier, H. Köpf, E. W. Neuse, Angew. Chem. 1984, 96, 446-447; Angew. Chem. Int. Ed. Engl. 1984, 23, 456-457;
8. b) E. W. Neuse, B. S. Mojapelo, J. Ensling, Transition Met. Chem. 1985, 10, 135-141;
9. c) N. Motohashi, R. Meyer, S. R. Gollapudi, K. R. Bhattiprolu, J. Organomet. Chem. 1990, 398, 205-217;
10. d) C.-W. Ong, J.-Y. Jeng, S.-S. Juang, C.-F. Chen, Bioorg. Med. Chem. Let. 1992, 2, 929-932;
11. e) L. V. Popova, V. N. Babin, Y. A. Belousov, Y. S. Nekrasov, A. E. Snegireva, N. P. Borodina, G. M. Shaposhnikova, O. B. Bychenko, P. M. Raevskii, N. B. Morozova, A. I. Iiyina, K. G. Shitkov, Appl. Organomet. Chem. 1993, 7, 85-94;
12. f) V. J. Fiorina, R. J. Dubois, S. Brynes, J. Med. Chem. 1978, 21, 393-395.
13. A. Houlton, R. M. G. Roberts, J. Silver, J. Organomet. Chem. 1991, 418, 107-112.
14. 2 = 0.0650 Crystallographic data (excluding structure factors) for the structures reported in this paper have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication no. CCDC-100113. Copies of the data can be obtained free of charge on application to The Director, CCDC, 12 Union Road, Cambridge CB21EZ, UK (fax: int. code +(1223)336-033; e-mail: deposit@chemcrys.cam.ac.uk).
15. Y.-K. Yan, D. M. P. Mingos, T. E. Müller, D. J. Williams, M. Kurmoo, J. Chem. Soc. Dalton Trans. 1994, 1735-1741.
16. -1 after 3 d are considered to be significantly active in reducing tumor cell growth.
17. 6 were inactive as cytotoxic agents in L-1210 cells. They also did not suppress DNA or RNA syntheses over 60 min at 100 mM. See also: I. H. Hall, A. E. Warren, C. C. Lee, M. D. Wasczcak, L. G. Sneddon, Anticancer Res. submitted.
18. R. I. Geran, N. H. Greenberg, M. M. Macdonald, A. M. Schumacher, B. J. Abbott, Cancer Chemother. Rep. Part 3 1972, 3, 7-24.
19. A. Leibovitz, J. C. Stinson, W. B. McCombs III, C. E. McCoy, K. C. Mazur, N. D. Mabry, Cancer Res. 1976, 36, 4562-4569.
20. L.-L. Liao, S. M. Kupchan, S. B. Horwitz, Mol. Pharmacol. 1976, 12, 167-176.
21. L. F. Liu, J. L. Davis, R. Calendar, Nuclei Acids Res. 1981, 9, 3979-3989.
22. K. G. Miller, L. F. Liu, P. T. Englund, J. Biol. Chem. 1981, 256, 9334-9339.